Find upcoming presentations, industry seminars, conference appearances, CPE events, and symposiums near you!
In high-stakes negotiations, asking thoughtful questions and strategically using silence can be surprisingly effective. Read on for details.
On a recent episode of ACG’s GrowthTV, Scott Linch, national industry leader of private equity at FORVIS, and Bob Dunn, managing director of GF Data, share their insights into a unique economic environment and its impact on dealmaking.
FORVIS Capital Advisors provides an in-depth analysis of M&A activity in senior living facilities in 2022. Read on for details.
Buyers and sellers should evaluate how inflation affects earnings and working capital, including how to normalize operating results. Read on for more.
Read about how interest rate hikes, inflation levels, and supply chain challenges impacted the Transportation & Logistics M&A landscape in 2022.
Integrity Pharmacy looked to FORVIS as a lead advisor for succession planning.
A proof of cash focuses on cash basis revenue and EBITDA to try to ground financial statements with a third-party source document. Read on for more.
Innovative medtech and biotech companies consider government grants, early seed funding, and VC funding to access capital. Learn how the TAP program can help.
With U.S. private companies adopting ASC 842, see how the new standard may affect M&A transactions.
A dealmaker approaching the closing table without having contemplated the difference between month-end and mid-month working capital balances could be facing significant purchase price adjustments, insufficient working capital, or a delay in closing…